BackAfterNext HealthTech Acquisition Overview

AfterNext HealthTech Acquisition EBIT

Track AfterNext HealthTech Acquisition's EBIT ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$0.00

As of Mar 31, 2023

Annual EBIT (TTM)

$0.00

Trailing 12 months ending Mar 31, 2023

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

AfterNext HealthTech Acquisition (AFTR) FAQ

The latest EBIT for AFTR is $0 as of March 2023. That is above the sector sector average of $-6.4M. Investors often review this figure alongside AfterNext HealthTech Acquisition's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, AFTR currently prints $0 for EBIT, while the sector average sits near $-6.4M. That is roughly 100.0% above the sector mean. Large gaps often invite a closer look at AfterNext HealthTech Acquisition's growth, margins, and balance sheet.

A EBIT figure of $0 for AFTR is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-6.4M. Explore the charts below for those layers of context.

After noting AFTR's EBIT ($0), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.